About
Generics
Areas of Focus
Categories
Generic DrugOther European
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
717
By Phase
PHASE1: 2PHASE3: 1PHASE4: 1
By Status
COMPLETED: 4
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05361369Lead Sponsor
Bioavailability Study of EVEGYN 600 mg/1000 mg/100 mg Vaginal Ovule
PHASE1Completed
18 participants
Started: May 9, 2022 · Completed: Mar 15, 2023
NCT06056947Collaborator
Evaluation of Efficacy and Safety of Two New Formulations Compared to Gynomax® XL Ovule
PHASE3Completed
577 participants
Started: Jul 20, 2020 · Completed: Aug 26, 2021
NCT03839875Lead Sponsor
Evaluation of Efficacy and Safety of Gynomax® XL Ovule
PHASE4Completed
116 participants
Started: Apr 3, 2019 · Completed: Aug 9, 2019
NCT03739541Lead Sponsor
Benznidazole Absorption, Metabolism and Excretion Study
PHASE1Completed
6 participants
Started: Jul 16, 2018 · Completed: Sep 2, 2018
Locations (1)
Headquarters
Etiler, Istanbul, Turkey
Map
Loading map...